These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26296136)
1. Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer. Wu X; Lin Q; Chen G; Lu J; Zeng Y; Chen X; Yan J PLoS One; 2015; 10(8):e0135714. PubMed ID: 26296136 [TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer]. Ge J; Yan B; Cao XC Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525 [TBL] [Abstract][Full Text] [Related]
4. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Goyal A; Newcombe RG; Chhabra A; Mansel RE; Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308 [TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961 [TBL] [Abstract][Full Text] [Related]
6. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R; Peintinger F; Rettenbacher L; Prokop E J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778 [TBL] [Abstract][Full Text] [Related]
8. [Detection of sentinel lymph node in patients with early stage breast cancer]. Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435 [TBL] [Abstract][Full Text] [Related]
9. Sentinel Node Biopsy Examination for Breast Cancer in a Routine Laboratory Practice: Results of a Pilot Study. Khoo JJ; Ng CS; Sabaratnam S; Arulanantham S Asian Pac J Cancer Prev; 2016; 17(3):1149-55. PubMed ID: 27039740 [TBL] [Abstract][Full Text] [Related]
10. Initial experience with sentinel lymph node mapping and biopsy in breast cancer. Preliminary results on 80 consecutive patients. D'Eredità G; Mele M; Serio G; Giardina C; Natale T; Martellotta M; Ferrarese F J Exp Clin Cancer Res; 2001 Dec; 20(4):469-72. PubMed ID: 11876538 [TBL] [Abstract][Full Text] [Related]
11. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial. van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336 [TBL] [Abstract][Full Text] [Related]
12. Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer. Xie F; Zhang D; Cheng L; Yu L; Yang L; Tong F; Liu H; Wang S; Wang S World J Surg Oncol; 2015 Nov; 13():319. PubMed ID: 26585236 [TBL] [Abstract][Full Text] [Related]
13. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph node biopsy in breast cancer patients: experience of a single center]. Yang B; Zheng G; Zuo WS; Yang L; Wang YS; Zheng MZ; Liu YS; Yu ZY Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):389-93. PubMed ID: 24054019 [TBL] [Abstract][Full Text] [Related]
15. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412 [TBL] [Abstract][Full Text] [Related]
16. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making. Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008 [TBL] [Abstract][Full Text] [Related]
17. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Boughey JC; Ballman KV; Le-Petross HT; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Feliberti EC; Hunt KK Ann Surg; 2016 Apr; 263(4):802-7. PubMed ID: 26649589 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in patients with multifocal breast cancer. Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M; Eur J Surg Oncol; 2004 Jun; 30(5):475-9. PubMed ID: 15135472 [TBL] [Abstract][Full Text] [Related]
19. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Chung MH; Ye W; Giuliano AE Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008 [TBL] [Abstract][Full Text] [Related]
20. Value of sentinel lymph node biopsy in breast cancer surgery with simple pathology facilities--an Iranian local experience with a review of potential causes of false negative results. Amoui M; Akbari ME; Tajeddini A; Nafisi N; Raziei G; Modares SM; Hashemi M Asian Pac J Cancer Prev; 2012; 13(11):5385-9. PubMed ID: 23317188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]